Market Overview:
The global long read sequencing market size is expected to exhibit a growth rate (CAGR) of 20.79% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate 2024-2032 |
20.79% |
Long read sequencing (LRS) improves de novo assembly, mapping certainty, transcript isoform identification, and detection of structural variants. It also eliminates amplification bias while preserving base modifications. On account of these capabilities, LRS finds a broad range of applications in genomics for both model and non-model organisms. Moreover, compared to the next-generation sequencing (NGS) approach, LRS technology produces high-quality genome assemblies, captures clinically relevant genomic elements, and offers improvements in the characterization of genetic variation and regions.
The rising number of individuals suffering from genetic disorders, along with the increasing acceptance of modern approaches for medical diagnostics, represents one of the key factors bolstering the market growth. The escalating demand for LRS technology can also be attributed to its portability and real-time speed. It is also used to produce an accurate reference map of the centromere of the chromosomes. Apart from this, various biotech companies are developing innovative technologies that combine a new library prep method and genome analysis tools. In line with this, several studies indicate that LRS technology plays a crucial role in discovering novel pathogenic mutations in human diseases with unknown genetic causes. This presents numerous opportunities to researchers for using the technology in whole-genome sequencing (WGS) and enabling advancements in medical genetics. Furthermore, the rising utilization of sequence analysis methodologies in medical institutes for academic purposes, in confluence with the increasing investments in research and development (R&D) activities, is anticipated to drive the market growth further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global long read sequencing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology, product, application and end use.
Breakup by Technology:
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing
Breakup by Product:
- Instruments
- Consumables
- Others
Breakup by Application:
- Whole Genome Sequencing
- Epigenetics
- RNA Sequencing
- Targeted Sequencing
- Others
Breakup by End Use:
- Academic and Research Institutes
- Hospitals and Clinics
- Pharma and Biotech Companies
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BaseClear B.V., Future Genomics Technologies B.V., Genexa AG, MicrobesNG, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Promega Corporation, Quantapore Inc., Roche Sequencing (F. Hoffmann-La Roche AG), Takara Bio Inc. and Thermo Fisher Scientific Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Technology, Product, Application, End Use, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
BaseClear B.V., Future Genomics Technologies B.V., Genexa AG, MicrobesNG, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Promega Corporation, Quantapore Inc., Roche Sequencing (F. Hoffmann-La Roche AG), Takara Bio Inc. and Thermo Fisher Scientific Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global long read sequencing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global long read sequencing market?
- What are the key regional markets?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global long read sequencing market and who are the key players?
- What is the degree of competition in the industry?